Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof
US8673290B2 · kind B2 · utility
0Cited by
8References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 27, 2012 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Feb 27, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel strains and methods for their use are provided. Particularly, foods and other oral products or treatments containing sporulation-deficient Brevibacillus strain when administered to a subject can inhibit or reduce the number of pathogens in the subject and improve the health of the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.